Your browser doesn't support javascript.
loading
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
Nicholls, Stephen J; Brewer, H Bryan; Kastelein, John J P; Krueger, Kathryn A; Wang, Ming-Dauh; Shao, Mingyuan; Hu, Bo; McErlean, Ellen; Nissen, Steven E.
Affiliation
  • Nicholls SJ; Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic, Cleveland, OH 44195, USA. nichols1@ccf.org
JAMA ; 306(19): 2099-109, 2011 Nov 16.
Article in En | MEDLINE | ID: mdl-22089718

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzodiazepines / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Cholesterol Ester Transfer Proteins / Cholesterol, HDL / Cholesterol, LDL Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2011 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzodiazepines / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Cholesterol Ester Transfer Proteins / Cholesterol, HDL / Cholesterol, LDL Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2011 Type: Article Affiliation country: United States